Table 1.
Regimens | Dosage and Administrationa | |
---|---|---|
TBI/CY | ||
TBIa | 2 Gy, twice/day | Days −6, −5, −4 |
Cyclophosphamide | 60 mg/kg, once/day | Days −3, −2 |
Granisetron | 3 mg, twice/day | Days −6 to −2 |
Aprepitantb | Once/day | 125 mg on day −3; 80 mg on days −2, −1 |
BU/CY | ||
Busulfan | 0.8 mg/kg, every 6 hrs | Days −7 to −4 |
Cyclophosphamide | 60 mg/kg, once/day | Days −3, −2 |
Granisetron | 3 mg, twice/day | Days −7 to −2 |
Aprepitantb | Once/day | 125 mg on day −7; 80 mg on days −6 to −2 |
Flu/BU4 | ||
Fludarabine | 30 mg/m2, once/day | Days −8 to −3 |
Busulfan | 0.8 mg/kg, every 6 hrs | Days −6 to −3 |
TBI (for UR donor) | 2 Gy, once/day | Day −1 |
Granisetron | 3 mg, twice/day | Days −8 to −3, −1 |
Aprepitantb | Once/day | 125 mg on day −6; 80 mg on days −5 to −3 |
Flu/BU2 | ||
Fludarabine | 30 mg/m2, once/day | Days −8 to −3 |
Busulfan | 0.8 mg/kg, every 6 hrs | Days −6, −5 |
TBI (for UR donor) | 2 Gy, once/day | Day −1 |
Granisetron | 3 mg, twice/day | Days −8 to −3, −1 |
Aprepitantb | Once/day | 125 mg on day −6; 80 mg on days −5, −4 |
Flu/CY | ||
Fludarabine | 25 mg/m2, once/day | Days −5 to −1 |
Cyclophosphamide | 30–60 mg/kg, once/day | Days −7, −6 |
Granisetron | 3 mg, twice/day | Days −7 to −1 |
Aprepitantb | Once/day | 125 mg on day −7; 80 mg on days −6, −5 |
Flu/MEL/TBI | ||
Fludarabine | 25 mg/m2, once/day | Days −8 to −4 |
Melphalan | 40 mg/m2, once/day | Days −3, −2 |
TBI | 2 Gy, once or twice/day | Day −1 |
Granisetron | 3 mg, twice/day | Days −8 to −1 |
Aprepitantb | Once/day | 125 mg on day −3; 80 mg on days −2, −1 |
TBI = total body irradiation; CY = cyclophosphamide; BU = busulfan; UR = unrelated donor; Flu = fludarabine; MEL = melphalan.
Hematopoietic stem cell transplantation (HSCT) was performed on day 0.
Patients in the control group did not receive aprepitant.